Atria Wealth Solutions, Inc. Abb Vie Inc. Transaction History

Atria Wealth Solutions, Inc.

$8.79 Billion
Q2 2024

A detailed history of Atria Wealth Solutions, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 157,987 shares of ABBV stock, worth $31.2 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

157,987

Previous 168,446 6.21%

Holding current value

$31.2 Million

Previous $30.7 Million 11.66%

% of portfolio

0.31%

Previous 0.36%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$154.79 - $180.76 $1.62 Million - $1.89 Million	-10,459 Reduced 6.21%	157,987 $27.1 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $3.37 Million - $3.84 Million	21,062 Added 14.29%	168,446 $30.7 Million
Q4 2023 Feb 02, 2024	BUY	$137.6 - $154.97 $249,881 - $281,425	1,816 Added 1.25%	147,384 $22.8 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $1.19 Million - $1.38 Million	8,923 Added 6.53%	145,568 $21.7 Million
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $1.59 Million - $1.98 Million	-11,995 Reduced 8.07%	136,645 $18.4 Million
Q1 2023 Aug 22, 2023	SELL	$144.61 - $166.54 $119,737 - $137,895	-828 Reduced 0.61%	135,817 $21.6 Million
Q1 2023 Jun 14, 2023	BUY	$144.61 - $166.54 $1.85 Million - $2.14 Million	12,823 Added 9.44%	148,640 $23.7 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $2.61 Million - $3 Million	-18,018 Reduced 11.71%	135,817 $21.6 Million
Q4 2022 Aug 30, 2023	BUY	$138.31 - $165.87 $1.66 Million - $1.99 Million	11,995 Added 8.78%	148,640 $24 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $765,130 - $917,592	5,532 Added 3.73%	153,835 $24.9 Million
Q3 2022 Feb 13, 2023	SELL	$134.21 - $153.93 $1.48 Million - $1.7 Million	-11,040 Reduced 6.93%	148,303 $19.9 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $4.65 Million - $5.34 Million	34,659 Added 27.8%	159,343 $22 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $2.24 Million - $2.85 Million	16,310 Added 15.05%	124,684 $19.1 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $14.3 Million - $17.7 Million	108,374 New	108,374 $17.6 Million

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.

Account

Atria Wealth Solutions, Inc. Abb Vie Inc. Transaction History